G. Kojouharoff

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

G. Kojouharoff, Wolfgang Hans, Florian Obermeier et al. · Clinical & Experimental Immunology · 1997 · 320 citations · Full text

Inflammation, Tumour Necrosis Factor, Anti-inflammatory +14

Interferon-gamma (IFN-γ)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice

Florian Obermeier, G. Kojouharoff, Wolfgang Hans et al. · Clinical & Experimental Immunology · 1999 · 309 citations · Full text

Chronic Inflammatory Diseases, Tumour Necrosis Factor, Toxic Effector Molecule +19

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

Volker Heinemann, Ursula Vehling‐Kaiser, Dirk Waldschmidt et al. · Gut · 2012 · 120 citations · Full text

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

Stefan Boeck, Andreas Jung, Rüdiger P. Laubender et al. · British Journal of Cancer · 2012 · 115 citations · Full text

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8